BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu R, Luo C, Pang Z, Zhang J, Ruan S, Wu M, Wang L, Sun T, Li N, Han L, Shi J, Huang Y, Guo W, Peng S, Zhou W, Gao H. Advances of nanoparticles as drug delivery systems for disease diagnosis and treatment. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.05.032] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhao X, Guo H, Bera H, Jiang H, Chen Y, Guo X, Tian X, Cun D, Yang M. Engineering Transferrin-Decorated Pullulan-Based Prodrug Nanoparticles for Redox Responsive Paclitaxel Delivery to Metastatic Lung Cancer Cells. ACS Appl Mater Interfaces 2023;15:4441-57. [PMID: 36633929 DOI: 10.1021/acsami.2c18422] [Reference Citation Analysis]
2 Jiang X, Wang N, Liu C, Zhuo Y, Liang L, Gan Y, Yu M. Oral delivery of nucleic acid therapeutics: challenges, strategies, and opportunities. Drug Discov Today 2023;:103507. [PMID: 36690175 DOI: 10.1016/j.drudis.2023.103507] [Reference Citation Analysis]
3 Zhang H, Zhao Z, Sun S, Zhang S, Wang Y, Zhang X, Sun J, He Z, Zhang S, Luo C. Molecularly self-fueled nano-penetrator for nonpharmaceutical treatment of thrombosis and ischemic stroke. Nat Commun 2023;14:255. [PMID: 36650139 DOI: 10.1038/s41467-023-35895-5] [Reference Citation Analysis]
4 Liu Y, Wang X, Wang Z, Liao R, Qiu Q, Wang Y, Luo C. Reduction-Responsive Stearyl Alcohol-Cabazitaxel Prodrug Nanoassemblies for Cancer Chemotherapy. Pharmaceutics 2023;15. [PMID: 36678891 DOI: 10.3390/pharmaceutics15010262] [Reference Citation Analysis]
5 Yang F, Kong Z, Ji Q, Li S, Sun J, He Z, Zhang S, Luo C. Platelet-Inspired Nanotherapeutics for Biomedical Applications. ACS Materials Lett 2023. [DOI: 10.1021/acsmaterialslett.2c00832] [Reference Citation Analysis]
6 Wang YJ, Tang L, Lu XH, Liu JT, Wang YY, Geng HX, Li XT, An Q. Efficacy of epi-1 modified epirubicin and curcumin encapsulated liposomes targeting-EpCAM in the inhibition of epithelial ovarian cancer cells. J Liposome Res 2022;:1-17. [PMID: 36440599 DOI: 10.1080/08982104.2022.2153138] [Reference Citation Analysis]
7 Liao C, Wang X, Zhou X, Wang D, Zhang Z, Liu Y, Wu X, Chen Y, Tan Y, Dai X, Jing P, Pang J, Xiao X, Liu J, Liao X, Zhang S. Dietary Antioxidant-Constructed Nanodrugs Can High-Efficiently Kill Cancer Cells while Protecting Noncancer Cells. ACS Appl Mater Interfaces 2022. [DOI: 10.1021/acsami.2c12043] [Reference Citation Analysis]
8 Nakamura M, Fujiwara K, Doi N. Cytoplasmic delivery of siRNA using human-derived membrane penetration-enhancing peptide. J Nanobiotechnology 2022;20:458. [PMID: 36303212 DOI: 10.1186/s12951-022-01667-4] [Reference Citation Analysis]
9 Wang Q, Wang Z, Sun X, Jiang Q, Sun B, He Z, Zhang S, Luo C, Sun J. Lymph node-targeting nanovaccines for cancer immunotherapy. J Control Release 2022;351:102-22. [PMID: 36115556 DOI: 10.1016/j.jconrel.2022.09.015] [Reference Citation Analysis]
10 Liu Y, Guo H, Xu R, Chen W. Smart intraoral systems for advanced drug delivery. MedComm – Biomaterials and Applications 2022;1. [DOI: 10.1002/mba2.19] [Reference Citation Analysis]
11 Wang X, Zhang D, Bai Y, Zhang J, Wang L. Enzyme-Powered Micro/Nanomotors for Cancer Treatment. Chem Asian J 2022;:e202200498. [PMID: 35676200 DOI: 10.1002/asia.202200498] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]